Chemical formula: C₂₂H₁₉ClN₄O₅ Molecular mass: 454.863 g/mol PubChem compound: 9911830
Tivozanib is indicated for:
Population group: only adults (18 years old or older)
Tivozanib is indicated for the first line treatment of adult patients with advanced renal cell carcinoma (RCC) and for adult patients who are VEGFR and mTOR pathway inhibitor-naïve following disease progression after one prior treatment with cytokine therapy for advanced RCC.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Tivozanib is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
